| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||








From the * Endocrinology Division, Central Drug
Research Institute, Lucknow, India; the
Centre
for Cellular and Molecular Biology, Uppal Road, Hyderabad, India, and the
Departments of Human Genetics and
Urology, Sri Ramachandra Medical College and
Research Institute (Deemed University), Porur, Chennai, India.
| Correspondence to: K Thangaraj, Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India (e-mail: thangs{at}ccmb.res.in). |
Testosterone is converted to 5
-dihydrotestosterone (DHT) by 5
-reductase enzyme, which is encoded by the SRD5A2 gene. DHT is
the main androgen responsible for prostate growth. We have analyzed the
complete coding region of the SRD5A2 gene in 87 histologically
confirmed prostate cancer (PC) patients, 40 benign prostatic hyperplasia (BPH)
cases, and 96 control samples from southern parts of India. The study revealed
the A49T site to be monomorphic, the V89L site to be highly polymorphic, and
the (TA)n repeat site to be polymorphic with only 2
alleles in our populations. The distribution of V89L alleles between PC cases
and controls was not significantly different; however, (TA)9
alleles distributed differently between the 2 groups. BPH cases exhibited
alleles similar to controls at all polymorphic sites. The sequencing of the
whole coding region did not reveal any other known or novel polymorphism in
this gene. Our study emphasizes that the (TA)9 allele might confer
certain PC risk but that A49T and V89L polymorphisms do not confer PC risk in
South Indian men.
Key words: South Indian population, 5
reductase, testosterone, dihydrotestosterone, benign prostatic hyperplasia
This article has been cited by other articles:
![]() |
X. Li, Y. Huang, X. Fu, C. Chen, D. Zhang, L. Yan, Y. Xie, Y. Mao, and Y. Li Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer Mutagenesis, May 1, 2011; 26(3): 371 - 383. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |